Nasdaq-listed, Washington state-based Concur, the travel and expense management company, will acquire GlobalExpense, a UK competitor, for 12 million pounds sterling plus a potential earn-out of up to 2 million pounds more. Concur was advised by Taylor Wessing LLP on the transaction.
3 min read · 07 June 2011
This is Unfortunate: Seems there was a patent suit filed against Skype as its Microsoft deal was closing Good Enough for Lobster: Former SAC trader testifies on “perfect” inside tips Nails Off the Numbers: Dykstra charged with grand theft auto, drug possession No Culprit? German officials can’t say what tipped off E. coli outbreak now
1 min read · 07 June 2011
3 min read · 07 June 2011
Visible Assets just boosted its visibility. The tracking-technology company just added Richard A. Clarke to its board of directors and is seeking as much as $20 million from VC backers, which would bring its aggregate cash raised to nearly $50 million. Today, Visible Assets announced Clarke would join its board. The addition of the former senior White House homeland security and counter-terrorism advisor and chairman and CEO of Good Harbor Consulting may help the New Hampshire-based real-time security tracking device company procure more federal contracts. But Visible Assets' tracking products
1 min read · 07 June 2011
Mu Sigma, the Chicago-based provider of analytics services, revealed it took a $25 million Series C from Sequoia Capital, the California-based VC. Shailendra Singh, a managing director at Sequoia, worked on the transaction. FTV Capital is among Mu Sigma’s other investors.
4 min read · 06 June 2011
Ernest Waaser has been appointed CEO and director at Systagenix Wound Management, a UK-based wound care provider. Steve Atkinson, the departing CEO, will continue to work with One Equity Partners as a consultant and advisor on medical device investments. One Equity counts Systagenix—formerly Johnson & Johnson’s wound care business—among its healthcare and medical device portfolio companies.
2 min read · 06 June 2011
1 min read · 06 June 2011
Wicked Deals: Beantown loyals help Groupon’s revenue base Steve! As Apple’s latest product—its new cloud—continues to gain hype, CEO Jobs is expected to speak Bad News: 247wallst.com says the next recession has begun Taking Their Sweet Time: The story of Nelson Obus, who’s been battling the SEC for nearly a decade
1 min read · 06 June 2011
It’s tough to tune into an economics debate on TV these days without seeing a split screen and pundits on each side of it arguing the merits and metrics of a third round of quantitative easing. QE3 might come as early as this summer and—depending on which side of the screen you listen to—is necessary to save the U.S. economy from getting sucked into the European Union’s fiscal downdraft, or is yet another wrongheaded call to punt the proverbial can only further into the future. Aside from the debate around QE3—every day, we seem closer to needing it. It is the timing of its implementation that will drastically impact private equity firms’ investment strategies and capacity to achieve attractive lending terms. However, PE pros have no tea leaves to definitively....
3 min read · 03 June 2011
PE’s Jake & Elwood: What won’t the Gores boys try and buy into? Drill, Baby! OPEC says greater oil output needed Dollar General: Shares take a slide, but 247wallst.com argues for why investors (and, PE buyers) want to take a second look at the discount champ Thank Goodness! Shares get a boost before jobs data
1 min read · 02 June 2011
